ロード中...
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer (NSCLC) patients in clinical studies. In the present study, we evaluated the antitumor effects of nintedanib in 16 NSCLC cell lines and trie...
保存先:
| 出版年: | Int J Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750530/ https://ncbi.nlm.nih.gov/pubmed/26783187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3331 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|